Join to View Full Profile
975 Sereno DrVallejo, CA 94589
Phone+1 707-651-1000
Dr. Kolevska is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1999 - 2002
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1996 - 1999
University of Zagreb Faculty of MedicineClass of 1986
Certifications & Licensure
CA State Medical License 2002 - 2026
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer Start of enrollment: 2005 Aug 01
- Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
- PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery Start of enrollment: 2012 Jun 12
- Join now to see all
Publications & Presentations
PubMed
- Patient factors and modifications to intended chemotherapy for women with Stages I-IIIA breast cancer.Jenna Bhimani, Peng Wang, Grace B Gallagher, Kelli O'Connell, Victoria Blinder
International Journal of Cancer. 2025-10-01 - NSABP FC-11: A phase II study of neratinib plus trastuzumab or neratinib plus cetuximab in patients with "quadruple wild-type" (KRAS/NRAS/BRAF/PIK3CA) metastatic color...Tanner J Freeman, Thomas J George, Samuel A Jacobs, Greg Yothers, Tatjana Kolevska
Cancer Chemotherapy and Pharmacology. 2025-08-09 - Patient characteristics associated with conventional schedule vs. dose dense chemotherapy in women with stage I-IIIA breast cancer.Jenna Bhimani, Peng Wang, Grace B Gallagher, Kelli O'Connell, Sonia Persaud
Breast Cancer Research and Treatment. 2025-08-01
Press Mentions
Improving Care for Cancer Survivors: Bridging the Gap Between Oncology and Primary CareSeptember 19th, 2025- Research Finds Cancer Patients Often Do Better with Less Intensive TreatmentDecember 8th, 2024
- How the Telehealth Revolution Is Transforming Cancer CareOctober 10th, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
